Back to Peptides
RecoveryLow Risk

Splenin

Also known as: Spleen peptide bioregulator, Lys-Glu-Asp-Gly

Half-life:
Unknown

Administration Routes

subcutaneous injectionintramuscular injection
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Mechanism of Action

Spleen-derived tetrapeptide bioregulator; normalizes leukocyte and platelet production; modulates splenic immune cell activity

A Khavinson bioregulator peptide derived from spleen tissue. Supports immune cell production and splenic function, particularly useful after immune depletion or illness.

Primary Research Areas

  • immune restoration
  • blood cell production
  • splenic function support

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Consult a healthcare professional before use.

Regulatory Status

Research OnlyNot Evaluated by FDA

Russian peptide bioregulator from spleen (Khavinson Institute). Immunomodulatory. No FDA approval, no NDA or IND. Not on any FDA list. Research chemical in US only.

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Where to Find Splenin

No active associated providers listed yet.